New Multisite Study Highlights Regulatory Fragmentation, Operational Bottlenecks, and the Critical Role of Investigators. A new study, led by Hospital Clinic de Barcelona and Fundació de Recerca Clínic Barcelona – Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in close collaboration with BCCC, examining the operational challenges and site-selection determinants at six European university hospitals when conducting Early Feasibility Studies (EFS) for medical devices has been published… Read more »

Barcelona Clinical Coordinating Center (BCCC), serving as the European Authorized Representative of Revamp Medical Inc. and responsible for the coordination of study activities in Spain, announces the successful completion of the DORAYA-HF OUS EFS study evaluating the safety, feasibility, and clinical performance of the Doraya Catheter for the treatment of volume overload in patients hospitalized… Read more »

Barcelona Clinical Coordinating Center (BCCC), acting as the national coordinating contract research organization (CRO) for Spain, celebrates the successful completion of patient recruitment in the PRIMARY study evaluating the long-term safety and effectiveness of transcatheter edge-to-edge repair (TEER) compared with surgical repair in patients with primary degenerative mitral regurgitation. Sponsored by the National Institutes of… Read more »

The CHOICE-2 randomized clinical trial, coordinated by Hospital Clínic Barcelona and IDIBAPS, has been published in JAMA (Journal of American Medical Association). The study demonstrates that administering intra-arterial alteplase immediately after mechanical thrombectomy significantly improves functional outcomes in severe ischemic stroke. The centralized analysis of brain imaging data across the 14-site Spanish trial was conducted by the BCCC Imaging Core Lab.  Key Results  Among the 440 patients enrolled,… Read more »

Barcelona Clinical Coordinating Center (BCCC), the lead non-profit contract research organization (CRO) coordinating patient recruitment and clinical operations, announces the completion of patient enrollment in the ANGIODAPT-01 trial, a randomized controlled study evaluating an abbreviated dual antiplatelet therapy (DAPT) regimen following drug-eluting stent implantation. The trial has been sponsored by iVascular, a company developing innovative… Read more »

Barcelona Clinical Coordinating Center (BCCC), the non-profit contract research organization responsible for clinical coordination and patient recruitment, announces the completion of enrollment in the OPAL study, a first-in-human and pivotal clinical study evaluating the novel embolic liquid system Amber, sponsored by iVascular, a company developing innovative advanced medical devices and therapies for the treatment of… Read more »